Xenovaccination of patients with skin melanoma: phase I/II clinical trial

被引：0
|
作者：
Moiseyenko, Vladimir [1 ]
Baldueva, I. [1 ]
Danilov, A. [1 ]
Danilov, A. [1 ]
机构：
[1] Russian Biotechnol, Moscow, Russia
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
    Mudigonda, Tejaswi V.
    Wyman, Kenneth
    Spigel, David R.
    Dahlman, Kimberly B.
    Greco, F. Anthony
    Puzanov, Igor
    Kelley, Mark C.
    Hainsworth, John D.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    PIGMENT CELL & MELANOMA RESEARCH, 2016, 29 (01) : 101 - 103
  • [22] Ipilimumab in a Phase II trial of melanoma patients with brain metastases
    Margolin, Kim
    ONCOIMMUNOLOGY, 2012, 1 (07) : 1197 - 1199
  • [23] Phase II trial of imatinib mesylate in patients with metastatic melanoma
    K B Kim
    O Eton
    D W Davis
    M L Frazier
    D J McConkey
    A H Diwan
    N E Papadopoulos
    A Y Bedikian
    L H Camacho
    M I Ross
    J N Cormier
    J E Gershenwald
    J E Lee
    P F Mansfield
    L A Billings
    C S Ng
    C Charnsangavej
    M Bar-Eli
    M M Johnson
    A J Murgo
    V G Prieto
    British Journal of Cancer, 2008, 99 : 734 - 740
  • [24] PHASE-II TRIAL OF MITOLACTOL IN PATIENTS WITH METASTATIC MELANOMA
    MEDINA, W
    KIRKWOOD, JM
    CANCER TREATMENT REPORTS, 1982, 66 (01): : 195 - 196
  • [25] Phase II trial of weekly paclitaxel in patients with advanced melanoma
    Walker, L
    Schalch, H
    King, DM
    Dietrich, L
    Eastman, M
    Kwak, M
    Kim, K
    Albertini, MR
    MELANOMA RESEARCH, 2005, 15 (05) : 453 - 459
  • [26] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH METASTATIC MELANOMA
    MACKEL, C
    MEYSKENS, FL
    ALBERTS, DS
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1037 - 1038
  • [27] PHASE-II TRIAL OF ESORUBICIN IN PATIENTS WITH ADVANCED MELANOMA
    FRUSTACI, S
    GASPARINI, G
    GALLIGIONI, E
    TIRELLI, U
    DIPIETRO, N
    CRIVELLARI, D
    LORE, G
    MONFARDINI, S
    CANCER TREATMENT REPORTS, 1987, 71 (03): : 325 - 326
  • [28] PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED MELANOMA
    CASPER, ES
    BAJORIN, D
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 187 - 190
  • [29] Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Shah, G. D.
    Socci, N. D.
    Gold, J. S.
    Wolchok, J. D.
    Carvajal, R. D.
    Panageas, K. S.
    Viale, A.
    Brady, M. S.
    Coit, D. G.
    Chapman, P. B.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1718 - 1722
  • [30] A phase II trial of arsenic trioxide in patients with metastatic melanoma
    Kim, KB
    Bedikian, AY
    Camacho, LH
    Papadopoulos, NE
    McCullough, C
    CANCER, 2005, 104 (08) : 1687 - 1692
12345